Balchem Corporation(BCPC)Earnings, Financials & Key RatiosBalchem Corporation (BCPC) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company maintains a robust balance sheet with only $33.7 million in total debt, the current P/E of 36.05 appears to fully price in the growth outlook while ignoring potential regulatory headwinds.
Balchem Corporation (BCPC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Balchem Corporation (BCPC) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $1.25vs $1.43-12.6% | $271Mvs $267M+1.6% |
| Q1 2026 | Feb 20, 2026 | $1.31vs $1.29+1.6% | $264Mvs $260M+1.6% |
| Q4 2025 | Oct 21, 2025 | $1.35vs $1.36-0.7% | $268Mvs $260M+3.1% |
| Q3 2025 | Jul 31, 2025 | $1.27vs $1.25+1.6% | $255Mvs $258M-0.8% |
Recent stock market news and headlines for Balchem Corporation (BCPC)
MONTVALE, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026.
Key metrics vs top competitors for Balchem Corporation (BCPC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $168.11 | $5.38B | 35.39 | 8.75% | 14.93% | 12.86% | 0.52% | |
| $98.57 | $6.22B | 8.82 | -2.84% | 9.36% | 15.48% | — | |
| $81.83 | $20.9B | -56.05 | -5.17% | 7.78% | 5.88% | — | |
| $38.10 | $3.49B | 42.81 | 0.61% | 4.81% | 6.6% | — | |
| $136.26 | $2.84B | 34.85 | 11.21% | 7.52% | 15.96% | — | |
| $81.66 | $2.01B | 17.49 | -3.65% | 6.38% | 8.64% | — |
Balchem Corporation (BCPC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Balchem Corporation (BCPC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 30, 2026·SEC
Feb 20, 2026·SEC
Feb 19, 2026·SEC
Get notified when BCPC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Balchem Corporation (BCPC) stock FAQ — growth, dividends, profitability & financials explained
Balchem Corporation (BCPC) reported $1.06B in revenue for fiscal year 2025. This represents a 3905% increase from $26.4M in 1996.
Balchem Corporation (BCPC) grew revenue by 8.8% over the past year. This is steady growth.
Yes, Balchem Corporation (BCPC) is profitable, generating $158.1M in net income for fiscal year 2025 (14.9% net margin).
Yes, Balchem Corporation (BCPC) pays a dividend with a yield of 0.52%. This makes it attractive for income-focused investors.
Balchem Corporation (BCPC) has a return on equity (ROE) of 12.9%. This is reasonable for most industries.
Balchem Corporation (BCPC) generated $182.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
